Arid
DOI10.1080/00480169.2011.609476
Efficacy of tropicamide, homatropine, cyclopentolate, atropine and hyoscine as mydriatics in Angora goats
Whelan, N. C.; Castillo-Alcala, F.; Lizarraga, I.
通讯作者Whelan, N. C.
来源期刊NEW ZEALAND VETERINARY JOURNAL
ISSN0048-0169
出版年2011
卷号59期号:6页码:328-331
英文摘要

AIM: To document the efficacy of five commercially available mydriatics for their potential for diagnostic and therapeutic use in Angora goats.


METHODS: Over 8 weeks, the mydriatic effects of 1% tropicamide, 2% homatropine, 1% cyclopentolate, 1% atropine and 0.25% hyoscine were evaluated. Given as block treatments, drugs were applied randomly to one eye of 10 Angora goats, and the contralateral eye served as a control. Vertical and horizontal pupil diameters were measured to document onset of effect, time to reach a difference of 5 mm in the vertical/horizontal pupil diameter between eyes, time to maximum pupillary dilation, and duration of mydriatic action.


RESULTS: Onset of mydriasis for all drugs occurred within 15 minutes. Time to reach a difference of 5 mm in the vertical pupil diameter between eyes was shortest for 1% tropicamide and 0.25% hyoscine (0.5 h), then 2% homatropine and 1% atropine (0.75 h), and longest for 1% cyclopentolate (1.5 h). The maximum vertical pupillary dilation occurred earliest with 1% tropicamide and 1% atropine (2 h), followed by 0.25% hyoscine (3 h), 2% homatropine (4 h), and latest with 1% cyclopentolate (8 h). The duration of vertical dilation of the pupil was shortest with 1% tropicamide (6 h), then 2% homatropine (12 h), 1% cyclopentolate (12 h), 1% atropine (24 h), and longest for 0.25% hyoscine (96 h). The time to reach maximum horizontal dilation of the pupil in treated eyes was shortest with 1% cyclopentolate (1 h), followed by 1% tropicamide (1.5 h), 0.25% hyoscine (3 h), 2% homatropine (3.5 h), and 1% atropine (4 h). The duration of horizontal pupil dilation was shortest with 1% tropicamide (4.5 h), and longest with 0.25% hyoscine (48 h).


CONCLUSION: All five mydriatics induced clinical dilation. Tropicamide (1%) had the shortest duration of effect, but gave incomplete dilation. Good dilation was achieved with 1% cyclopentolate and 2% homatropine, but took too long to reach maximum dilation for routine mydriasis. The largest vertical dilation of the pupil was achieved with 1% atropine and 0.25% hyoscine, but pupils remained dilated for more than 24 h.


CLINICAL RELEVANCE: For routine mydriasis in goats, it is recommended that 1% tropicamide be used, though there may be incomplete dilation. For a longer duration of mydriasis, such as in the treatment of anterior uveitis, 1% atropine or 0.25% hyoscine would be the drugs of choice.


英文关键词Goat caprine mydriatic pupil tropicamide homatropine cyclopentolate atropine hyoscine muscarinic parasympatholytic
类型Article
语种英语
国家New Zealand
收录类别SCI-E
WOS记录号WOS:000298113200011
WOS关键词EQUINE PUPIL ; NUBIAN GOATS ; DESERT SHEEP ; KERATOCONJUNCTIVITIS ; SULFATE ; EYE
WOS类目Veterinary Sciences
WOS研究方向Veterinary Sciences
资源类型期刊论文
条目标识符http://119.78.100.177/qdio/handle/2XILL650/169788
作者单位Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North 4442, New Zealand
推荐引用方式
GB/T 7714
Whelan, N. C.,Castillo-Alcala, F.,Lizarraga, I.. Efficacy of tropicamide, homatropine, cyclopentolate, atropine and hyoscine as mydriatics in Angora goats[J],2011,59(6):328-331.
APA Whelan, N. C.,Castillo-Alcala, F.,&Lizarraga, I..(2011).Efficacy of tropicamide, homatropine, cyclopentolate, atropine and hyoscine as mydriatics in Angora goats.NEW ZEALAND VETERINARY JOURNAL,59(6),328-331.
MLA Whelan, N. C.,et al."Efficacy of tropicamide, homatropine, cyclopentolate, atropine and hyoscine as mydriatics in Angora goats".NEW ZEALAND VETERINARY JOURNAL 59.6(2011):328-331.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Whelan, N. C.]的文章
[Castillo-Alcala, F.]的文章
[Lizarraga, I.]的文章
百度学术
百度学术中相似的文章
[Whelan, N. C.]的文章
[Castillo-Alcala, F.]的文章
[Lizarraga, I.]的文章
必应学术
必应学术中相似的文章
[Whelan, N. C.]的文章
[Castillo-Alcala, F.]的文章
[Lizarraga, I.]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。